secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001607062-23-000142
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.02, 3.03
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 15K Series NC preferred shares to CEO with super-voting rights
--------------------------------------------------------------------------------

- Issued 15,000 Series NC preferred shares to CEO David Koos to settle $10,050 debt.
- Each Series NC share carries 334 votes, disproportionately high voting power.
- Issuance dilutes common stock voting power and has anti-takeover effect.
- Board authorized 20,000 shares of Series NC; 15,000 issued now.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000142/0001607062-23-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000142/rgbp032023form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-23-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer